Meeting
2023 ASCO Genitourinary Cancers Symposium
A national questionnaire survey of Japanese urologists on the treatment perspective for elderly patients with prostate cancer.
Authors
Takuma Kato
Kagawa University Graduate School of Medicine, Kagawa, Japan
Takuma Kato , Yoichiro Tohi , Tomoko Honda , Iori Matsuda , Yu Osaki , Hirohito Naito , Yuki Matsuoka , Homare Okazoe , Rikiya Taoka , Nobufumi Ueda , Mikio Sugimoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 327)
DOI
10.1200/JCO.2023.41.6_suppl.327
Abstract #
327
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.
First Author: David Joseph Benjamin
Poster
2021 ASCO Annual Meeting
Identifying androgen receptor (AR) and genomic characteristics that define populations of patients with mHSPC who benefit from early PARP inhibition therapy with talazoparib.
First Author: Saro Kasparian
Poster
2020 Genitourinary Cancers Symposium
Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.
First Author: Alexandra Sokolova
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols